These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 8875224
21. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification. Vallance H, Morris TJ, Coulter-Mackie M, Lim-Steele J, Kaback M. Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452 [Abstract] [Full Text] [Related]
22. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients. Bayleran J, Hechtman P, Kolodny E, Kaback M. Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149 [Abstract] [Full Text] [Related]
23. Identification of candidate active site residues in lysosomal beta-hexosaminidase A. Fernandes MJ, Yew S, Leclerc D, Henrissat B, Vorgias CE, Gravel RA, Hechtman P, Kaplan F. J Biol Chem; 1997 Jan 10; 272(2):814-20. PubMed ID: 8995368 [Abstract] [Full Text] [Related]
24. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Nat Genet; 1996 Nov 10; 14(3):348-52. PubMed ID: 8896570 [Abstract] [Full Text] [Related]
25. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A. Hoffman LM, Brooks SE, Amsterdam D, Oropello J, Schneck L. J Neurosci Res; 1980 Nov 10; 5(5):413-7. PubMed ID: 7441795 [Abstract] [Full Text] [Related]
26. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation. Elsafi ME, Elbashir MI, Hultberg B, Isaksson A, Hägerstrand I, Stenram U. Scand J Clin Lab Invest; 1991 Dec 10; 51(8):711-4. PubMed ID: 1839650 [Abstract] [Full Text] [Related]
27. Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Drucker L, Hemli JA, Navon R. Hum Mutat; 1997 Dec 10; 10(6):451-7. PubMed ID: 9401008 [Abstract] [Full Text] [Related]
28. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts. Hechtman P, Khoo K, Isaacs C. Clin Genet; 1983 Sep 10; 24(3):206-15. PubMed ID: 6226462 [Abstract] [Full Text] [Related]
29. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. Lemieux MJ, Mark BL, Cherney MM, Withers SG, Mahuran DJ, James MN. J Mol Biol; 2006 Jun 16; 359(4):913-29. PubMed ID: 16698036 [Abstract] [Full Text] [Related]
30. Molecular basis of heat labile hexosaminidase B among Jews and Arabs. Narkis G, Adam A, Jaber L, Pennybacker M, Proia RL, Navon R. Hum Mutat; 1997 Jun 16; 10(6):424-9. PubMed ID: 9401004 [Abstract] [Full Text] [Related]
31. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A. Navon R, Kopel R, Nutman J, Frisch A, Conzelmann E, Sandhoff K, Adam A. Am J Hum Genet; 1985 Jan 16; 37(1):138-46. PubMed ID: 3156493 [Abstract] [Full Text] [Related]
32. Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice. Guidotti JE, Mignon A, Haase G, Caillaud C, McDonell N, Kahn A, Poenaru L. Hum Mol Genet; 1999 May 16; 8(5):831-8. PubMed ID: 10196372 [Abstract] [Full Text] [Related]
33. Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity. Hoon DS, Kaback MM, Lim-Steele J, Tsuchida T, Morton DL, Irie RF. Biochem Int; 1992 Jul 16; 27(2):343-52. PubMed ID: 1386984 [Abstract] [Full Text] [Related]
34. Metabolic correction in microglia derived from Sandhoff disease model mice. Tsuji D, Kuroki A, Ishibashi Y, Itakura T, Itoh K. J Neurochem; 2005 Sep 16; 94(6):1631-8. PubMed ID: 16092933 [Abstract] [Full Text] [Related]
35. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease. Guetta E, Peleg L. Methods Mol Biol; 2008 Sep 16; 444():147-59. PubMed ID: 18425478 [Abstract] [Full Text] [Related]
36. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases]. Beĭer EM, Vidershaĭn GIa, Venert M. Biull Eksp Biol Med; 1984 Jan 16; 97(1):83-6. PubMed ID: 6229294 [Abstract] [Full Text] [Related]
37. cDNA clone for the alpha-chain of human beta-hexosaminidase: deficiency of alpha-chain mRNA in Ashkenazi Tay-Sachs fibroblasts. Myerowitz R, Proia RL. Proc Natl Acad Sci U S A; 1984 Sep 16; 81(17):5394-8. PubMed ID: 6236461 [Abstract] [Full Text] [Related]
38. A new point mutation within exon 5 of beta-hexosaminidase alpha gene in a Japanese infant with Tay-Sachs disease. Nakano T, Nanba E, Tanaka A, Ohno K, Suzuki Y, Suzuki K. Ann Neurol; 1990 May 16; 27(5):465-73. PubMed ID: 2141777 [Abstract] [Full Text] [Related]
39. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Lacorazza HD, Flax JD, Snyder EY, Jendoubi M. Nat Med; 1996 Apr 16; 2(4):424-9. PubMed ID: 8597952 [Abstract] [Full Text] [Related]
40. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta. Arfi A, Zisling R, Richard E, Batista L, Poenaru L, Futerman AH, Caillaud C. J Neurochem; 2006 Mar 16; 96(6):1572-9. PubMed ID: 16441513 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]